Varenicline-induced psychotic depressive episode in a patient with bipolar disorder

Therapeutic Advances in Psychopharmacology

Volumn 2, Issue 1, 2012, Pages 35-37

  Annagur, Bilge Burcak ^a   Bez, Yasin ^a  

^a NONE

Author keywords

bipolar disorder; side effect; varenicline

Indexed keywords

AMISULPRIDE; QUETIAPINE; VARENICLINE;

ADULT; AGITATION; BIPOLAR DISORDER; CASE REPORT; DECEPTION; DEPRESSIVE PSYCHOSIS; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DSM-IV; HUMAN; INSOMNIA; LETTER; MALE; PARANOIA; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; SUICIDAL IDEATION;

EID: 84997941800     PISSN: 20451253     EISSN: 20451261     Source Type: Journal    
DOI: 10.1177/2045125311430111     Document Type: Letter

References (16)

1. Benowitz N.L. (2008) Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83: 531–541.
2. Cahill K. Stead L. Lancaster T. (2009) A preliminary benefit–risk assessment of varenicline in smoking cessation. Drug Safety 32: 119–135.
3. Cousins D.A. Butts K. Young A.H. (2009) The role of dopamine in bipolar disorder. Bipolar Disord 11: 787–806.
4. DiPaula B.A. Thomas M.D. (2009) Worsening psychosis induced by varenicline in a hospitalized psychiatric patient. Pharmacotherapy 29: 852–857.
5. Food and Drug Administration (2008) FDA Med Watch Alert, Varenicline (marketed as Chantix): Information, 20 November 2007 and 1 February 2008. Available at: http://www.fda.gov/cder/drug/infopage/varenicline/default.htm (accessed 20 April 2011).
6. Gunnell D. Irvine D. Wise L. Davies C. Martin R.M. (2009) Varenicline and suicidal behavior: a cohort study based on data from the General Practice Research Database. BMJ 339: b3805.
7. Hall S.M. Prochaska J. (2009) Treatment of smokers with cooccurring disorders: Emphasis on integration in mental health and addiction treatment settings. Ann Rev Clin Psychol 5: 409–431.
8. Hays J.T. Ebert J.O. (2008) Varenicline for tobacco dependence. N Engl J Med 359: 2018–2024.
9. Hughes J.R. (2008) Smoking and suicide: a brief overview. Drug Alcohol Depend 98: 169–178.
10. Kohen I. Kremen N. (2007) Varenicline-induced manic episode in a patient with bipolar disorder. Am J Psychiatry 164: 1269–1270.
11. Kuehn B.M. (2009) Varenicline gets stronger warnings about psychiatric problems, vehicle crashes. J Am Med Assoc 302: 834.
12. Pumariega A.J. Nelson R. Rotenberg L. (2008) Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS Spectr 13: 511–514.
13. Scatton B. Claustre Y. Cudennec A. Oblin A. Perrault G. Sanger D.J. et al. (1997) Amisulpride: from animal pharmacology to therapeutic action. Int Clin Psychopharmacol 12(2): S29–S36.
14. Xi Z.X. (2010) Preclinical pharmacology, efficacy and safety of varenicline in smoking cessation and clinical utility in high risk patients. Drug Healthc Patient Saf 2: 39–48.
15. Williams K.E. Reeves K.R. Billing C.B. Jr Pennington A.M. Gong J. (2007) A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin 23: 793–801.
16. Ziedonis D.M. Hitsman B. Beckham J.C. Zvolensky M. Adler L.E. Adurain-McGovern J. et al. (2008) Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tobacco Res 10: 1691–1715.